SHANGHAI, China, Feb. 10 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced members of the Company's management will present at the upcoming Roth Capital Partners 21st Annual OC Growth Stock Conference held February 16-18, 2009, in Dana Point, California.
The date, time and location of China-Biotics' presentation at the conference is as follows:
Roth Capital Partners 21st Annual OC Growth Stock Conference Date: Tuesday, February 17, 2009 Time: 11:00 a.m. Pacific Time Venue: Track 5 The Ritz-Carlton, Laguna Niguel One Ritz-Carlton Drive Dana Point, California 92629
The Roth 21st Annual OC Growth Stock Conference will bring together executives from approximately 200 growth companies. This event is designed to provide investors with a unique opportunity to gain insight into leading companies across all sectors. The Company's management will present at the conference. For more information, please view http://www.roth.com or email firstname.lastname@example.org .
About China-Biotics, Inc.
China-Biotics, Inc. ("China-Biotics," "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company has operations in Shanghai. Its proprietary product portfolio contains live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang. China-Biotics plans to launch 300 Shining brand retail outlets in major cities in China. Currently, China-Biotics is strategically expanding its production capacity of probiotics to meet growing demand in the bulk additive market. For more information, please visit http://www.chn-biotics.com .
For more information, please contact: CCG Investor Relations Crocker Coulson, President Phone: +1-646-213-1915 (New York) Email: email@example.com Web: http://www.ccgirasia.com
|SOURCE China-Biotics, Inc.|
Copyright©2009 PR Newswire.
All rights reserved